Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background.: Few studies have investigated the efficacy of repetitive transcranial magnetic stimulation (rTMS) treatment for negative symptoms of schizophrenia, reporting inconsistent results. We aimed to investigate whether 10 Hz stimulation of the bilateral dorsolateral prefrontal cortex during 3 weeks enhances treatment effects. Method.: A multicenter double-blind randomized controlled trial was performed in 32 patients with schizophrenia or schizo-affective disorder, and moderate to severe negative symptoms [Positive and Negative Syndrome Scale (PANSS) negative subscale ⩾15]. Patients were randomized to a 3-week course of active or sham rTMS. Primary outcome was severity of negative symptoms as measured with the Scale for the Assessment of Negative Symptoms (SANS) and the PANSS negative symptom score. Secondary outcome measures included cognition, insight, quality of life and mood. Subjects were followed up at 4 weeks and at 3 months. For analysis of the data a mixed-effects linear model was used. Results.: A significant improvement of the SANS in the active group compared with sham up to 3 months follow-up (p = 0.03) was found. The PANSS negative symptom scores did not show a significant change (p = 0.19). Of the cognitive tests, only one showed a significant improvement after rTMS as compared with sham. Finally, a significant change of insight was found with better scores in the treatment group. Conclusions.: Bilateral 10 Hz prefrontal rTMS reduced negative symptoms, as measured with the SANS. More studies are needed to investigate optimal parameters for rTMS, the cognitive effects and the neural basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
Grant, D. A., & Berg, E. (1948) · Journal of Experimental Psychology · doi:10.1037/h0059831 · Cited by 2,244
Strafella, A. P., Paus, T., Barrett, J., & Dagher, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-j0003.2001 · Cited by 1,058
An efficient and accurate new method for locating the F3 position for prefrontal TMS applications
Beam, W., Borckardt, J. J., Reeves, S. T., & George, M. S. (2009) · Brain Stimulation · doi:10.1016/j.brs.2008.09.006 · Cited by 626
Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000512 · Cited by 620
Lisanby, S. H., Gutman, D., Luber, B., Schroeder, C., & Sackeim, H. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01110-0 · Cited by 442
Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics: A Meta-Analysis
Lako, I. M., van den Heuvel, E. R., Knegtering, H., Bruggeman, R., & Taxis, K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182983ffa · Cited by 125 · cited 2×
“…Syndrome Scale; MADRS, Montgomery–Åsberg Depression Rating Scale; WHOQOL-BREF, World Health Organization Quality of Life-BREF. a Dopamine D2 receptor occupancy as a percentage was estimated for each participant according to the prescribed dose of antipsychotic medication (Lako et al. 2013).”
MethodSelf-citation
Cited by
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
Self-citationBegemann, M. J., Brand, B. A., Ćurčić-Blake, B., Aleman, A., & Sommer, I. E. (2020) · Psychological Medicine · doi:10.1017/s0033291720003670 · Cited by 368
“…6y ± 5.2 10 10 A/V, EF, PS, SC Sham 14 34 (22–59) 21 6y ± 8.7 10 Rabany, Deutsch, and Levkovitz (2014) Double Left DLPFC 20 33 ± 11.31 35 AAO: 21 ± 9.8 20 20 A/V, WM, EF, PS Sham 10 36 ± 11.0 20 AAO: 26 ± 8.3 20 Dlabac-De Lange et al. (2015) Double Bilateral DLPFC 16 42 ± 11.6 13 16y ± 10.1 10 30…”
InfluentialSelf-citationIimori, T., Nakajima, S., Miyazaki, T., Tarumi, R., Ogyu, K., Wada, M., Tsugawa, S., Masuda, F., Daskalakis, Z. J., Blumberger, D. M., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.014 · Cited by 94
Martin, D. M., McClintock, S. M., Forster, J., & Loo, C. K. (2016) · Neuropsychology Review · doi:10.1007/s11065-016-9325-1 · Cited by 76
Metadata
- Authors
- Dlabac-de Lange, J. J., Bais, L., van Es, F. D., Visser, B. G. J., Reinink, E., Bakker, B., van den Heuvel, E. R., Aleman, A., & Knegtering, H.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2014-10-30
- Volume
- 45
- Issue
- 6
- Pages
- 1263-1275
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2118757555
- Cited by
- 104
- References
- 7
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. https://app.cochat.ai/papers/10.1017/s0033291714002360
- The paper
- Dlabac-de Lange, J. J., Bais, L., van Es, F. D., Visser, B. G. J., Reinink, E., Bakker, B., van den Heuvel, E. R., Aleman, A., & Knegtering, H. (2015). Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. Psychological Medicine. https://doi.org/10.1017/s0033291714002360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.